» Articles » PMID: 32109340

Altered Proteomics Profile in the Amnion of Patients with Oligohydramnios

Overview
Journal Physiol Rep
Specialty Physiology
Date 2020 Feb 29
PMID 32109340
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

In pregnancy, idiopathic oligohydramnios is an obstetrical complication that compromises maternal health with poor perinatal outcome. Effective therapeutic treatment of this condition has been hampered by the unknown etiology and lack of understanding of cellular and molecular mechanisms that underlie idiopathic oligohydramnios. Amniotic fluid volume (AFV) is determined by intramembranous (IM) transport of amniotic fluid across the amnion and this pathway is regulated to maintain AFV within the normal range. To gain understanding of the causes of idiopathic oligohydramnios, we performed proteomics analysis of the human amnion to investigate the changes in protein expression profiles of cellular transport pathways and regulators in patients with oligohydramnios. Placental amnions from five patients with normal pregnancies and five patients with oligohydramnios were subjected to proteomics experiments followed by bioinformatics analysis. Using Ingenuity Pathway Analysis (IPA) software, five categories of biological functions and multiple canonical pathways within each category were revealed. The top differentially expressed proteins that participate in mediating these pathways were identified. The functional pathways activated include: (a) cellular assembly and organization, (b) cell signaling and energy metabolism, and (c) immunological, infectious, and inflammatory functions. Furthermore, the analysis identified the category of pathways that facilitate molecular endocytosis and vesicular uptake. Under oligohydramniotic conditions, the mediators of clathrin vesicle-mediated uptake and transport as well as intracellular trafficking mediators were up-regulated. These findings suggest that idiopathic oligohydramnios may be associated with alternations in cellular organization and immunological functions as well as increases in activity of vesicular transport pathways across the amnion.

Citing Articles

Window to the Womb: Amniotic Fluid and Postnatal Outcomes.

Whittington J, Ghahremani T, Friski A, Hamilton A, Magann E Int J Womens Health. 2023; 15:117-124.

PMID: 36756186 PMC: 9900144. DOI: 10.2147/IJWH.S378020.


Altered proteomics profile in the amnion of patients with oligohydramnios.

Cheung C, Brace R Physiol Rep. 2020; 8(4):e14381.

PMID: 32109340 PMC: 7048322. DOI: 10.14814/phy2.14381.

References
1.
Cabrales Fontela Y, Kadavath H, Biernat J, Riedel D, Mandelkow E, Zweckstetter M . Multivalent cross-linking of actin filaments and microtubules through the microtubule-associated protein Tau. Nat Commun. 2017; 8(1):1981. PMC: 5719408. DOI: 10.1038/s41467-017-02230-8. View

2.
Locatelli A, Vergani P, Toso L, Verderio M, Pezzullo J, Ghidini A . Perinatal outcome associated with oligohydramnios in uncomplicated term pregnancies. Arch Gynecol Obstet. 2003; 269(2):130-3. DOI: 10.1007/s00404-003-0525-6. View

3.
Cheung C, Anderson D, Brace R . Transport-associated pathway responses in ovine fetal membranes to changes in amniotic fluid dynamics. Physiol Rep. 2017; 5(20). PMC: 5661228. DOI: 10.14814/phy2.13455. View

4.
Cheung C, Brace R . Altered proteomics profile in the amnion of patients with oligohydramnios. Physiol Rep. 2020; 8(4):e14381. PMC: 7048322. DOI: 10.14814/phy2.14381. View

5.
Sharshiner R, Brace R, Cheung C . Vesicular uptake of macromolecules by human placental amniotic epithelial cells. Placenta. 2017; 57:137-143. PMC: 5657563. DOI: 10.1016/j.placenta.2017.06.344. View